Axonius Federal Systems Achieves FedRAMP Moderate Authorization, Advances Cybersecurity Modernization Across U.S. Federal Agencies
RESTON, Va., April 10, 2025 (GLOBE NEWSWIRE) -- Axonius Federal Systems, the…
European Commission Approves Pfizers RSV Vaccine ABRYSVO to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease
ABRYSVO is the first and only RSV vaccine approved in the European…
Glidian Joins Infinx to Advance Prior Authorization Automation and Expand Market Reach
MUMBAI, India and CUPERTINO, Calif., March 25, 2025 /PRNewswire/ -- Infinx, a…
MET DEVELOPMENT (MAIRE), ENI AND IREN START THE AUTHORIZATION PROCESS FOR A CIRCULAR METHANOL AND HYDROGEN PLANT IN ITALY BASED ON NEXTCHEM’S NX CIRCULARTM TECHNOLOGY
NEXTCHEM's NX CircularTM waste-to-energy gasification technology allows Eni's Sannazzaro de' Burgondi refinery…
Celltrion Receives EC Approval for Avtozma (CT-P47), a Biosimilar to RoActemra (tocilizumab)
Avtozma® (CT-P47), a biosimilar referencing RoActemra® (tocilizumab) is approved by the European…
Samsung Bioepis Gains European Commission (EC) Approval for Denosumab Biosimilar (OBODENCE, XBRYK)
OBODENCE™ and XBRYK™ approved by the European Commission (EC) for all indications…
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
FDA decision makes ZYN the first authorized nicotine pouch productScience-based decision affirms…
FDA Authorizes Myocene Device for Muscle Fatigue Monitoring and Informed Training Decisions
LIÈGE, Belgium, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Myocene, the Belgian sportstech…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…